Bicycle Therapeutics PLC (NASDAQ:BCYC)

Delayed Data
As of Aug 16
 -0.63 / -2.39%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 60.00, with a high estimate of 74.00 and a low estimate of 30.00. The median estimate represents a +133.74% increase from the last price of 25.67.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.16%
Growthannually -38.10%


Growthquarterly 50.88%
Growthannually 70.16%
Key to the earnings and sales forecast charts.